MedRx Co., Ltd (TYO:4586)
67.00
+1.00 (1.52%)
Aug 27, 2026, 3:30 PM JST
MedRx Revenue
MedRx had revenue of 6.00M JPY in the quarter ending June 30, 2026, a decrease of -62.50%. This brings the company's revenue in the last twelve months to 121.00M, up 175.00% year-over-year. In the year 2025, MedRx had annual revenue of 128.00M, down -50.19%.
Revenue (ttm)
121.00M
Revenue Growth
+175.00%
P/S Ratio
32.88
Revenue / Employee
5.76M
Employees
21
Market Cap
3.98B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 128.00M | -129.00M | -50.19% |
| Dec 31, 2024 | 257.00M | 228.00M | 786.21% |
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharma Foods International | 67.00B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 60.11B |
| Daito Pharmaceutical | 50.65B |
| Nippon Chemiphar | 33.02B |
| Koa Shoji Holdings | 24.68B |
| Morishita Jintan | 12.82B |
| Mizuho Medy | 10.82B |